HopeStage
Back to all studies
RecruitingNCT07281352

Psilocybin with 12-session CBT for depression

About this titleRead the official source — NCT07281352
Medication studyAges 21–60United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 21 years to 60 years.

Listed locations
Los AngelesSee all locations and recruitment
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: January 5, 2026
Recruitment status
Recruiting
Enrollment listed in the registry
50
Sponsor
University of California, Los Angeles
Sponsor type
University
Study type
Drug
Intervention type
Behavioural, Drug
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
United States
Age range
From 21 Years to 60 Years
Official registry ID
NCT07281352
Official title
Show the full official title

Psilocybin-Assisted Cognitive Behavioral Therapy for Depression

Recruitment & locations

Currently recruiting

Los Angeles

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of California, Los Angeles, a university.

Does this study involve medication?

Yes. The study involves medication, including Psilocybin (drug).

Who can participate?

Listed age limits: 21 years to 60 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies